Latest Prostate cancer Stories
Study Assesses Long-Term Safety and Efficacy of Targeted Radiation Therapy Delivered at the Time of Lumpectomy Using the Xoft® System® NASHUA, N.H., Dec.
- FDA-approved product further expands Endo's Branded Pharmaceutical Men's Health portfolio -( )Commercial launch planned for Q1 2015 DUBLIN, Dec.
Cambridge Laboratory Will Serve as Primary Location for Processing ProMark(TM), the Company's Newly-Launched Prostate Cancer Prognostic Test CAMBRIDGE, Mass., Dec.
Employees grow moustaches and raise money for Movember campaign ATLANTA, Dec.
Market Size - $448 million in 2013, Market Growth - CAGR of 26.2%, Market Trends - Growing commercialization rates in Asia Pacific - Latest report published by Grand View Research.
MELBOURNE, Australia, December 4, 2014 /PRNewswire/ -- Experts take major step towards maximising benefits and minimising harms
Studies Presented at the 2014 Society of Urologic Oncology Annual Meeting Demonstrate Test's Value to Physicians and Patients, Support Increased Adoption and Reimbursement REDWOOD
PORTLAND, Oregon, December 2, 2014 /PRNewswire/ -- Research Beam adds a report titled "Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive
Landmark Study Reconfirms Oncotype DX® Stratifies DCIS Patient Risk REDWOOD CITY, Calif., Dec. 2, 2014 /PRNewswire/ -- Genomic Health, Inc.
- A political dynamiter.
More Images (2 images) »